Gland Pharma Ltd 52 Week Low
Gland Pharma Ltd
NSE: GLAND
YEARLOW
Key Highlights
- The 52 Week Low of Gland Pharma Ltd is ₹ 1575 as of 28 Jul 26 .
Company Fundamentals for Gland Pharma Ltd
Market Price of Gland Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 28 Jul 2026 | 2427.25 |
| 27 Jul 2026 | 2427.8 |
| 24 Jul 2026 | 2378.35 |
| 23 Jul 2026 | 2377.55 |
| 22 Jul 2026 | 2440.25 |
| 21 Jul 2026 | 2484.35 |
| 20 Jul 2026 | 2459.5 |
| 17 Jul 2026 | 2449.75 |
| 16 Jul 2026 | 2533 |
| 15 Jul 2026 | 2463.8 |
Asset Value vs Market Value of Gland Pharma Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Gland Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Gland Pharma Ltd
Historical Net Profit of Gland Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Gland Pharma Ltd
Gland Pharma Ltd News Hub
Gland Pharma slides after Q1 PAT slumps 26% YoY to Rs 144 cr
Revenue from operations jumped 15.97% YoY to Rs 1,401.70 crore in Q1 FY25. Profit before tax (PBT) s
Read more
07 Aug 24
Gland Pharma consolidated net profit declines 25.94% in the June 2024 quarter
Net profit of Gland Pharma declined 25.94% to Rs 143.76 crore in the quarter ended June 2024 as agai
Read more
06 Aug 24
US FDA issues 3 Form 483 observations to Gland Pharma's Pashamylaram facility
The said inspection was conducted between 25 July 2024 and 02 August 2024. The said inspection was c
Read more
05 Aug 24
Gland Pharma Ltd gains for third straight session
Gland Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 1936.35, up 1
Read more
09 Sept 24
